greeksoup/ stock research
Stock research / United States / ANGO / Planned sales

Angiodynamics Inc. planned insider sales

In the last twelve months insiders at Angiodynamics Inc. filed 2 Form 144 notices of planned sales, 46,985 shares worth $633,726 at the time of filing, from 2 sellers. The latest, filed 29 October 2026: Stephen Trowbridge (officer), 23,615 shares worth $289,722, planned for around 29 October 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
29 October 2026Stephen TrowbridgeOfficer23,615$289,72229 October 2026None on Form 4 yetMorgan Stanley Smith Barney LLC Executive Financial ServicesEmployee Stock Purchase Plan; Performance Shares; Restricted StockForm 144
30 July 2026Warren NighanOfficer23,370$344,00430 July 202623,370 shares from 30 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesPerformance Shares; Restricted StockForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?